Efficacy and safety of port delivery platform with ranibizumab (PDS) for diabetic macular oedema (Pagoda Randomised Clinical Trial) - Summary - MDSpire
The provided context does not state the study objective.
Key Findings:
Malhotra et al. presented the PAGODA study results at the Association for Research in Vision and Ophthalmology meeting in Seattle, Washington, on May 5–9, 2024; Khanani et al. subsequently published them [1].
Interpretation:
The context provides no details about the trial methods, outcomes, or interpretation.
Limitations:
The provided context does not include study design details, participant characteristics, results, or safety outcomes.
